Wayne, Pennsylvania, United States
Currently seeking advisory, Board or consulting roles with early, development or commercial stage pharma/biotech organizations. Highly respected and successful leader with a functionally and geographically broad 30+ year track record, including a demonstrated ability to build and/or transform various operations and products into top performing and high-growth businesses and brands. Proven leadership skills ranging from CEO and Board Director of multiple biotech organizations to President/General Manager of Global business and major country affiliate. Strong P&L focus with the ability to leverage new and existing product opportunities, R&D, manufacturing and business development in order to assure a broad range of revenue and profit opportunities. Extensive global and U.S. product launch experience, including Prevnar family, Enbrel and Effexor XR. Significant fund raising and business development experience across wide range of sources and deal types. Successful track record across wide array of organization types (large Pharma to virtual biotech) and numerous specialty and primary care disease and therapeutic areas. Spent 24 years at Wyeth (now Pfizer) in series of general management, commercial and finance roles including EVP and GM, Wyeth Vaccines and President and GM, Wyeth Canada. More recently served as CEO of two biotech companies (Aeras and Tivorsan) and board director and/or advisor to various life science and investment organizations.
Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need.
IAVI is a nonprofit scientific organization dedicated to addressing urgent, unmet global health challenges including HIV and tuberculosis.
Currently serve on the Board of Directors for several organizations, including Valneva, IAVI and Covenant House PA. Formerly served on Aeras, PaxVax, Vaxess Technologies, Tivorsan and Ambulatus Robotics boards. Provide broad based consulting and advisory services to a variety of Pharma, biotech, vaccine and investment organizations covering commercial, corporate/business development, M&A, corporate strategy, product launches, fund raising, business start-up, organizational development and other areas. While serving on various boards, helped facilitate efforts to secure significant capital via VC/PE fund raising, PRV sale, company sale and other sources.
PaxVax is a specialty vaccine company focused on travelers and biodefense markets with a social mission to ensure global access to its vaccines. Supported efforts that resulted in securing additional capital (debt and PE financing and PRV sale) and sale of company.